Modeling Cancer with Pluripotent Stem Cells

被引：28

作者：

Gingold, Julian ^{[1
]}

Zhou, Ruoji ^{[2
,3
]}

Lemischka, Ihor R. ^{[4
,5
,6
]}

Lee, Dung-Fang ^{[2
,3
,7
]}

机构：

[1] Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH 44195 USA

[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA

[3] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA

[4] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA

[6] Icahn Sch Med Mt, Black Family Stem Cell Inst, New York, NY 10029 USA

[7] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA

来源：

TRENDS IN CANCER | 2016年 / 2卷 / 09期

关键词：

TARGETED GENE CORRECTION; FUNCTIONAL HUMAN LIVER; KIDNEY ORGANOIDS; HUMAN ES; DIRECTED DIFFERENTIATION; PROGENITOR CELLS; SELF-RENEWAL; IPS CELLS; GENERATION; DISEASE;

D O I：

10.1016/j.trecan.2016.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The elucidation of cancer pathogenesis has been hindered by limited access to patient samples, tumor heterogeneity, and the lack of reliable model organisms. Characterized by their ability to self-renew indefinitely and differentiate into all adult cell lineages of an organism, pluripotent stem cells (PSCs), including ESCs and induced pluripotent stem cells (iPSCs), provide a powerful and unlimited source to generate differentiated cells that can be used to study disease biology, facilitate drug discovery and development, and provide key insights for developing personalized therapies. This article reviews the recent developments and technologies converting PSCs into clinically relevant model systems for cancer research.

引用

页码：485 / 494

页数：10

共 50 条

[1] Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, Dandan
Kong, Celine Shuet Lin
Gingold, Julian A.
Zhao, Ruiying
Lee, Dung-Fang
CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 4: STEM CELLS AND CELL BASED STRATEGIES IN REGENERATION, 2018, 1119 : 169 - 183
[2] Modeling Familial Cancer with Induced Pluripotent Stem Cells
Lee, Dung-Fang
Su, Jie
Kim, Huen Suk
Chang, Betty
Papatsenko, Dmitri
Zhao, Ruiying
Yuan, Ye
Gingold, Julian
Xia, Weiya
Darr, Henia
Mirzayans, Razmik
Hung, Mien-Chie
Schaniel, Christoph
Lemischka, Ihor R.
CELL, 2015, 161 (02) : 240 - 254
[3] Pluripotent Stem Cells and Disease Modeling
Colman, Alan
Dreesen, Oliver
CELL STEM CELL, 2009, 5 (03) : 244 - 247
[4] Modeling human infertility with pluripotent stem cells
Chen, Di
Gell, Joanna J.
Tao, Yu
Sosa, Enrique
Clark, Amander T.
STEM CELL RESEARCH, 2017, 21 : 187 - 192
[5] Modeling neurodevelopment in a dish with pluripotent stem cells
Imaizumi, Kent
Okano, Hideyuki
DEVELOPMENT GROWTH & DIFFERENTIATION, 2021, 63 (01) : 18 - 25
[6] MODELING HUMAN HEMATOPOIESIS IN PLURIPOTENT STEM CELLS
Elefanty, Andrew
Ng, Elizabeth
Bruveris, Freya
Azzola, Lisa
Phipson, Belinda
Vlahos, Katerina
Leuitoguinho, Ana Rita
Calvanese, Vincenzo
Schenke-Layland, Katja
Oshlack, Alicia
Mikkola, Hanna
Stanley, Edouard
EXPERIMENTAL HEMATOLOGY, 2017, 53 : S30 - S30
[7] Modeling of osteosarcoma with induced pluripotent stem cells
Pang, Lon Kai
Pena, Mezthly
Zhao, Ruiying
Lee, Dung-Fang
STEM CELL RESEARCH, 2020, 49
[8] Interconversion of Cancer Cells and Induced Pluripotent Stem Cells
Sarker, Drishty B.
Xue, Yu
Mahmud, Faiza
Jocelyn, Jonathan A.
Sang, Qing-Xiang Amy
CELLS, 2024, 13 (02)
[9] Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
Kim, Huensuk
Schaniel, Christoph
FRONTIERS IN IMMUNOLOGY, 2018, 9
[10] Primary immunodeficiency modeling with induced pluripotent stem cells
Pessach, Itai M.
Notarangelo, Luigi D.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (06) : 505 - 511

← 1 2 3 4 5 →